For biomanufacturers and cold chain logistics, maintaining strict temperature control is nonnegotiable. Especially for the freeze-down of high-value assets like biologics, vaccines, advanced therapies and other temperature-sensitive drugs, precision freezing is essential to safeguard product stability and regulatory compliance.
To address these challenges, Klinge Corporation’s pharma container blast freezer delivers a dependable, ultra-low temperature solution which meets the requirements of modern pharmaceutical logistics. Designed to achieve and sustain temperatures down to -60° Celsius (-76° Fahrenheit), this blast freezer container enables manufacturers and logistics partners to meet or exceed their demanding freezing requirements.
Why Ultra-Low Temperature Freeze-Down Matters in Pharma
Proper ultra-low temperature freezing maintains product stability, minimizes degradation risk and supports compliance with regulated handling protocols. Freeze-down systems such as the CBU-30 are key elements in preparing pharmaceutical cargo for long-term storage or distribution pathways that require uniform thermal profiles — especially when freezing is part of batch release or quality control workflows.
For pharmaceutical companies, freeze-down at ultra-low temperatures preserves molecular stability, minimizes degradation rates and enables drugs to meet their complete shelf-life claims. Integrating a pharmaceutical storage freezer container into batch release and quality control workflows also means that teams can store and transport temperature-sensitive shipments, such as cell therapies or mRNA vaccines, with confidence.
Meeting Regulatory Compliance Standards
Our -60°C (-76°F) pharmaceutical freezer container delivers:
- Data logging and monitoring: Klinge Corporation’s solutions include microcontroller-based temperature data logging that records the supply and return temperatures. These records are stored securely with time stamps, allowing users to document equipment compliance with internal protocols and industry requirements for each cycle. Additional, product dataloggers are also used by the end customers to ensure product temperature compliance.
- Global deploying abilities for varied workflows: The CBU-30 enables deployment across diverse locations and supply chain nodes with its containerized, mobile footprint and robust thermal performance. It offers the flexibility to support vaccine campaigns, biologics distribution and pharmaceutical logistics while maintaining traceable temperature and process controls from origin to destination.
Mobile Ultra-Low Temperature Freezing for Pharmaceutical Processing
The CBU-30 Pharma Blast Freezer is a high-capacity, containerized blast freezing system engineered for low and ultra-low temperature freeze-down applications, including pharmaceutical products, biologics and temperature-sensitive materials. and phase change materials (PCMs). The system delivers consistent low-temperature performance, controlled airflow and repeatable freeze profiles essential for cold chain preparation and product quality assurance.
Built for mobility between operational sites, the CBU-30 combines the flexibility of a containerized platform with robust blast-freezing performance, rapid installation and controlled airflow dynamics suitable for deep freeze processing. Its industrial-grade refrigeration design and airflow configuration ensure even temperature distribution throughout the cargo load, which is critical for pharma freeze-down and downstream handling workflows.
Pharmaceutical manufacturers, research facilities and process engineers rely on advanced ultra-low temperature systems to prepare products for storage, distribution or further processing steps. The CBU-30 supports these workflows by delivering rapid and controlled freeze-down to -60°C (-76°F) with high velocity airflow performance.
Industrial-Grade Performance and Reliability
Unit uptime and reliability are at the core of the CBU-30. Built using top-tier industrial-grade refrigeration and mechanical components, this freezer is engineered for continuous duty cycles in demanding environments. Operators can count on uninterrupted performance, even through dense processing cycles or challenging ambient conditions.
Key performance features include:
- Rapid product core pull-down to ultra-low temperatures
- Consistent operations down to -60°C (-76°F) in all conditions
- High-static evaporator airflow for uniform freeze profiles
- Durable, wood-free structure for contamination control in pharma environments
- Industrial-duty refrigeration components for continuous operations
- Quick, easy installation at manufacturing sites
Technical Specifications
| Feature | Specification |
|---|---|
| Application | Ultra-low temperature pharma freeze-down |
| Operating Temperature Range | Ambient down to -60°C (-76°F) |
| Primary Function | Controlled freeze-down for temperature-sensitive materials |
| Container Format | ISO containerized structure |
| Dimensions (LxHxW) | 9′ x 9’6″ x 8′ (2.74m x 2.90m x 2.44m) |
| Mobility | Relocatable between facilities |
| Operation Mode | Stationary blast freezing system |
| Airflow Design | High-velocity, forced-air circulation |
| Evaporator System | Heavy-duty industrial evaporator |
| Air Distribution | Configurable ceiling plenum system |
| Refrigeration System | Ultra-low temperature industrial refrigeration |
| Duty Cycle | Continuous industrial operation |
| Typical Products | Biologics, vaccines, pharmaceuticals, research samples |
| Installation Locations | Manufacturing facilities, clinical labs, cold chain prep sites |
| Integration | Pre-storage or pre-distribution freeze-down |
Engineered for Pharmaceutical Cold Chain Preparation
Freeze-down performance is critical in pharmaceutical manufacturing, lab workflows and cold chain preparation for biologics. The CBU-30’s high-velocity airflow and deep-freeze capability help preserve product integrity and deliver repeatable freeze profiles across full pallet loads, which is essential when controlling the thermal history of temperature-sensitive pharmaceuticals.
Unlike general-purpose freezers, the CBU-30 is designed to support the stringent process control needed for pharma applications, including consistent airflow systems and industrial refrigeration components that ensure accurate temperature transition throughout the freeze cycle.
Typical Pharma Use Cases
Common deployment options could include:
- Controlled freeze-down for vaccines and biologics, as well as phase change materials for packaging
- Preparation of temperature-sensitive research materials
- Pre-storage conditioning before ultra-cold storage
- Deep-freeze processing for clinical trial logistics
Contact a Specialist at Klinge Today
Klinge Corporation’s ultra-low temperature solutions span far beyond the CBU-30. For complete cold chain coverage and redundant freezing during transport, learn more about our advanced pharma freezer container for transport and explore deep freezer solutions, including dual redundant -70°C pharmaceutical freezer containers.
From process design to production readiness, our experts help design workflows tailored to your pharma needs. Contact a Klinge Specialist today to discuss product configuration options or application requirements, or to receive a detailed quotation.